Identification of high-risk patients with a seven-biomarker prognostic signature for adjuvant treatment trial recruitment in American Joint Committee on Cancer v8 stage I–IIA cutaneous melanoma
- Resource Type
- Source
- European Journal of Cancer. 182:77-86
- Subject
Cancer Research Oncology - Language
- ISSN
- 0959-8049